Platelet-Rich Plasma and Combination Therapies for Dry Eye Disease: Current Advances and Future Directions
October 2025
in “
Transfusion Medicine and Hemotherapy
”
TLDR Platelet-rich plasma shows promise for treating dry eye disease, but more standardized trials are needed.
The review discusses the potential of platelet-rich plasma (PRP) in treating dry eye disease (DED), highlighting its mechanisms and clinical efficacy. It emphasizes the importance of standardized trials to confirm the effectiveness of PRP and explores innovative combination therapies, such as integrating PRP with biologics, advanced materials, or laser therapies. These approaches could significantly enhance precision medicine in managing DED.
